Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Dimebon

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Parkinson’s Disease Dementia

gene therapy1 - plaque in alzheimer's disease1 - reconceptualization1 - cognitive problems2 - risk of stroke1 - heart attack2 - functional imaging1 - high oestrogen levels1 - lewy body1 - multiple system atrophy1 - gum disease1 - sign of aging1 - olanzapine1 - paraphrenia1 - dementia and down’s syndrome1 - angina1 - glucose hypometabolism1 - imbecility1 - picks disease2 - morphometry1 - high cholesterol1 - decline in memory1 - small silent stroke1 - single-photon emission computed tomography1 - developing dementia2 - cholesterol-lowering drugs1 - frontotemporal dementia symptoms1 - neurotransmitter1 - anterograde amnesia10 - sinequan1 -